Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome

Human Reproduction

Volumn 30, Issue 9, 2015, Pages 2222-2233

  Kuang, Hongying ^a,b   Jin, Susan ^b   Hansen, Karl R ^c   Diamond, Michael P ^d   Coutifaris, Christos ^e   Casson, Peter ^f   Christman, Gregory ^g   Alvero, Ruben ^h   Huang, Hao ^b   Bates, G Wright ⁱ   Usadi, Rebecca ^j   Lucidi, Scott ^k   Baker, Valerie ^l   Santoro, Nanette ^h   Eisenberg, Esther ^m   Legro, Richard S ⁿ   Zhang, Heping ^b  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j CAROLINAS MEDICAL CENTER   (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^m EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁿ PENN STATE COLLEGE OF MEDICINE   (United States)

more..

Author keywords

calibration; conception; live birth; mathematical modeling; polycystic ovaries; prediction; pregnancy; receiver operating characteristic

Indexed keywords

ANDROGEN; CLOMIFENE CITRATE; INSULIN; LETROZOLE; METFORMIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL EVALUATION; CONCEPTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEMALE INFERTILITY; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; LIVE BIRTH; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; OVULATION; PHENOTYPE; PREDICTION; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SECONDARY ANALYSIS; SMOKING; TREATMENT DURATION; COMPLICATION; FERTILIZATION; INFERTILITY, FEMALE; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); THEORETICAL MODEL;

ADULT; FEMALE; FERTILIZATION; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; MODELS, THEORETICAL; OVULATION; POLYCYSTIC OVARY SYNDROME; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84940727103     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev182     Document Type: Article

References (23)

1. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245
3. Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, Curtis KM. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197: 223-228
4. Cupisti S, Häberle L, Dittrich R, Oppelt PG, Reissmann C, Kronawitter D, Beckmann MW, Mueller A. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. Fertil Steril 2010; 94: 673-677
5. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011
6. Hosmer DW, Lemeshow S A goodness-of-fit test for the multiple logistic regression model. Commun Stat 1980; A10: 1043-1069
7. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082
8. Lake JK, Power C, Cole TJ. Women's reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord 1997; 21: 432-438
9. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356: 551-566
10. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Alvero R, Casson P, Christman GM, Huang H, Yan Q et al. The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial. Fertil Steril 2014; 101: 258-269.e8
11. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014; 371: 119-129
12. Legro RS, Chen G, Kunselman AR, Schlaff WD, Diamond MP, Coutifaris C, Carson SA, Steinkampf MP, Carr BR, McGovern PG et al. Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. Hum Reprod 2014; 29: 2680-2686
13. Leushuis E, van der Steeg JW, Steures P, Bossuyt PM, Eijkemans MJ, van der Veen F, Mol BW, Hompes PG. Prediction models in reproductive medicine: a critical appraisal. Hum Reprod Update 2009; 15: 537-552
14. Metwally M, Saravelos SH, Ledger WL, Li TC. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 2010; 94: 290-295
15. Rausch ME, Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, McGovern PG, Cataldo NA et al. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94: 3458-3466
16. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-Term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
17. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013; 6: 1-13
18. Smith AD, Tilling K, Lawlor DA, Nelson SM. External validation and calibration of IVFpredict: a national prospective cohort study of 130, 960 in vitro fertilisation cycles. PLoS One 2015; 10: e0121357
19. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801-810
20. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 2248-2256
21. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
22. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008; 89: 505-522
23. Veltman-Verhulst SM, Fauser BCJM, Eijkemans MJ. High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. Fertil Steril 2012; 98: 761-768